Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Dizocilpine (MK801): use or abuse?

Article Abstract:

Medical studies show that the co-administration of dizocilpine with opiates and psychostimulants such as cocaine, amphetamine and nicotine, impedes the development of tolerance, dependence and sensitization to these drugs, as well as neuroadaptations in rodents. Thus, dizocilpine has great potentials of becoming useful for the treatment of drug addiction. When it was mixed with bromocriptine however, it was observed that it enhanced the development of behavioral sensitization.

Author: Vanderschuren, Louk J.M.J, Schoffelmeer, Anton N.M., Mulder, Arie H., Vries, Taco J.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1998
Research, Drug abuse, Transfer factor (Immunology), Transfer factor

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


In vivo studies with antisense oligonucleotides

Article Abstract:

First-generation antisense oligonucleotides have been tested as therapeutic agents among human beings. Antisense therapeutics is an exciting new technology for manipulating gene expression in the treatment of human viral diseases such as AIDS, inflammatory disorders and cancers. The ideal and efficient oligonucleotide delivery strategy will help improve efficacy, lessen side-effects and reduce drug costs.

Author: Akhtar, Saghir, Agrawal, Sudhir
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1997
Health aspects, Toxicity testing, Toxicity tests, Antisense nucleic acids

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: On the selectivity of 7-nitroindazole as an inhibitor of neuronal nitric oxide synthase. Phosphodiesterases: the journey towards therapeutics
  • Abstracts: The dioxin and peroxisome proliferator-activated receptors: nuclear receptors in search of endogenous ligands
  • Abstracts: Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities. Selective peptidomimetic blockers of autoantigen presentation: a novel therapeutic approach to autoimmune disease
  • Abstracts: Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities. part 2 Neuropeptides and nociception: recent advances and therapeutic implications
  • Abstracts: Nerve membrane Na+ channels as targets of insecticides. The role of excitotoxicity in organophosphorous nerve agents central poisoning
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.